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Clinics and pathology 
Disease 
ALL 
Phenotype / cell stem origin 
FAB L1 phenotype; pre-B immunophenotype, cIg+ or 
cIg- 
Epidemiology 
<1% of childhood ALL, age ≤6 years; 3% of childhood 
ALL with 9p abnormalities; rarely also found in eldrly 









Note: Several dicentric chromosomes found in 
childhood ALL are formed from the q arms of 
chromosomes 7, 9, 12, and, 17 with partial loss of the 
respective p arms. 
Cytogenetics, morphological 
Unbalanced; formation of a dicentric chromosome 
resulting in partial monosomies of 7p and 9p →
hypodiploid with 45 chromosomes 
Additional anomalies 
del(6q), dup(1p), del(8)(p22), … 
Genes involved and Proteins 
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